相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial
I-K. Wang et al.
BENEFICIAL MICROBES (2015)
Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD
Eikan Mishima et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Alterations of intestinal barrier and microbiota in chronic kidney disease
Alice Sabatino et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Intestinal microbiota, diet and health
Susan E. Power et al.
BRITISH JOURNAL OF NUTRITION (2014)
Gut Bacterial Translocation May Aggravate Microinflammation in Hemodialysis Patients
Kehui Shi et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
The microbiome and regulation of mucosal immunity
Andrew J. McDermott et al.
IMMUNOLOGY (2014)
Effects of a Symbiotic on Gut Microbiota in Mexican Patients With End-Stage Renal Disease
Jose Cruz-Mora et al.
JOURNAL OF RENAL NUTRITION (2014)
The Gut Microbiome, Kidney Disease, and Targeted Interventions
Ali Ramezani et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Effect of short-term synbiotic treatment on plasma p-cresol levels in patients with chronic renal failure: A randomized clinical trial
B. Guida et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2014)
High Amylose Resistant Starch Diet Ameliorates Oxidative Stress, Inflammation, and Progression of Chronic Kidney Disease
Nosratola D. Vaziri et al.
PLOS ONE (2014)
Gut microbiota-related complications in cirrhosis
Isabel Gomez-Hurtado et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Gut microbiota and metabolic syndrome
Davide Festi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trial
Megan Rossi et al.
BMC NEPHROLOGY (2014)
Colon may provide new therapeutic targets for treatment of chronic kidney disease with Chinese medicine
Zou Chuan et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2013)
Searching for Uremic Toxins
Mirela Dobre et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Redox signaling mediated by the gut microbiota
Andrew S. Neish
FREE RADICAL RESEARCH (2013)
Clinical and experimental use of probiotic formulations for management of end-stage renal disease: an update
Alessandro Di Cerbo et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2013)
The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease
Hans-Joachim Anders et al.
KIDNEY INTERNATIONAL (2013)
Chronic kidney disease alters intestinal microbial flora
Nosratola D. Vaziri et al.
KIDNEY INTERNATIONAL (2013)
Uremia and chronic kidney disease: The role of the gut microflora and therapies with pro- and prebiotics
Luis Vitetta et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2013)
Antioxidants for chronic kidney disease
Min Jun
NEPHROLOGY (2013)
From the Gastrointestinal Tract (GIT) to the Kidneys: Live Bacterial Cultures (Probiotics) Mediating Reductions of Uremic Toxin Levels via Free Radical Signaling
Luis Vitetta et al.
TOXINS (2013)
Pathophysiology of endotoxin tolerance: mechanisms and clinical consequences
Eduardo Lopez-Collazo et al.
CRITICAL CARE (2013)
Uremic Plasma Impairs Barrier Function and Depletes the Tight Junction Protein Constituents of Intestinal Epithelium
Nosratola D. Vaziri et al.
AMERICAN JOURNAL OF NEPHROLOGY (2012)
Probiotic Mechanisms of Action
Miriam Bermudez-Brito et al.
ANNALS OF NUTRITION AND METABOLISM (2012)
Bacteria, Colonic Fermentation, and Gastrointestinal Health
George T. Macfarlane et al.
JOURNAL OF AOAC INTERNATIONAL (2012)
Normal and Pathologic Concentrations of Uremic Toxins
Flore Duranton et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease
Vidya M. Raj Krishnamurthy et al.
KIDNEY INTERNATIONAL (2012)
Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients
Feiqian Wang et al.
NEPHROLOGY (2012)
Leaky gut and the liver: A role for bacterial transllocation in nonalcoholic steatohepatitis
Yaron Ilan
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Intestinal-Renal Syndrome: Mirage or Reality?
Eberhard Ritz
BLOOD PURIFICATION (2011)
Circulating Endotoxemia: A Novel Factor in Systemic Inflammation and Cardiovascular Disease in Chronic Kidney Disease
Christopher W. McIntyre et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Indoxyl Sulfate-Induced Endothelial Dysfunction in Patients with Chronic Kidney Disease via an Induction of Oxidative Stress
Mina Yu et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Effect of Phosphate Binders on Serum Inflammatory Profile, Soluble CD14, and Endotoxin Levels in Hemodialysis Patients
Juan F. Navarro-Gonzalez et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Inflammation as a risk factor and target for therapy in chronic kidney disease
Tetsu Miyamoto et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2011)
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
Gary D. Wu et al.
SCIENCE (2011)
Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease
Steven B. Deitelzweig et al.
ADVANCES IN THERAPY (2010)
Uraemic toxins for consideration by the cardiologist-Beyond traditional and non-traditional cardiovascular risk factors
Ziad A. Massy et al.
ATHEROSCLEROSIS (2010)
Serum levels of total p-cresylsulphate are associated with angiographic coronary atherosclerosis severity in stable angina patients with early stage of renal failure
Chao-Ping Wang et al.
ATHEROSCLEROSIS (2010)
Prebiotic effects: metabolic and health benefits
Marcel Roberfroid et al.
BRITISH JOURNAL OF NUTRITION (2010)
Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease
Sophie Liabeuf et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin
Bjoern K. I. Meijers et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Effect of Increasing Dialyzer Mass Transfer Area Coefficient and Dialysate Flow on Clearance of Protein-Bound Solutes: A Pilot Crossover Trial
Frank J. -G. Luo et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Circulating Bacterial-Derived DNA Fragments and Markers of Inflammation in Chronic Hemodialysis Patients
Maurizio Bossola et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada
Natarajan Ranganathan et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Sevelamer Hydrochloride Use and Circulating Endotoxin in Hemodialysis Patients: A Pilot Cross-Sectional Study
Phyllis P. Sun et al.
JOURNAL OF RENAL NUTRITION (2009)
Uremic toxins originating from colonic microbial metabolism
Pieter Evenepoel et al.
KIDNEY INTERNATIONAL (2009)
Why do patients on peritoneal dialysis have low blood levels of protein-bound solutes?
Raymond Vanholder et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2009)
Protein-Bound Toxins-Update 2009
Noemie Jourde-Chiche et al.
SEMINARS IN DIALYSIS (2009)
Endotoxin-binding affinity of sevelamer hydrochloride
Mary C. Perianayagam et al.
AMERICAN JOURNAL OF NEPHROLOGY (2008)
All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan
Chi Pang Wen et al.
LANCET (2008)
Bacterial-Modulated Signaling Pathways in Gut Homeostasis
Won-Jae Lee
SCIENCE SIGNALING (2008)
Innate immune response and hepatic inflammation
Gyongyi Szabo et al.
SEMINARS IN LIVER DISEASE (2007)
Gut microflora as a target for energy and metabolic homeostasis
Patrice D. Cani et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2007)
Healthy aging: regulation of the metabolome by cellular redox modulation and prooxidant signaling systems: The essential roles of superoxide anion and hydrogen peroxide
Anthony William Linnane et al.
BIOGERONTOLOGY (2007)
A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria
David S. Goldfarb et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells
L. Dou et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function
E. Cario et al.
GASTROENTEROLOGY (2007)
Epithelia: lymphocyte interactions in the gut
Stephanie Dahan et al.
IMMUNOLOGICAL REVIEWS (2007)
Increasing the clearance of protein-bound solutes by addition of a sorbent to the dialysate
Timothy W. Meyer et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Oral administration of AST-120 (Kremezin) is a promising therapeutic strategy for advanced glycation end product (AGE)-related disorders
S. Yamagishi et al.
MEDICAL HYPOTHESES (2007)
Prospective randomized study evaluating the efficacy of the spherical adsorptive carbon AST-120 in chronic kidney disease patients with moderate decrease in renal function
Tatsuya Shoji et al.
NEPHRON CLINICAL PRACTICE (2007)
Relationship between uremic toxins and oxidative stress in patients with chronic renal failure
Przemyslaw Rutkowski et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2007)
Effect of n-acetylcysteine on endothelial dysfunction in dialysis patients
Garip Sahin et al.
BLOOD PURIFICATION (2007)
Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients
Simone Goncalves et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
The gut flora as a forgotten organ
Ann M. O'Hara et al.
EMBO REPORTS (2006)
A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD
G Schulman et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Vitamin C prophylaxis promotes oxidative lipid damage during surgical ischemia-reperfusion
DM Bailey et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
The calcineurin phosphatase complex modulates immunogenic B cell responses
MM Winslow et al.
IMMUNITY (2006)
In vitro and in vivo assessment of intraintestinal bacteriotherapy in chronic kidney disease
N Ranganathan et al.
ASAIO JOURNAL (2006)
Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice
O Phan et al.
CIRCULATION (2005)
Use of a probiotic to decrease enteric hyperoxaluria
JC Lieske et al.
KIDNEY INTERNATIONAL (2005)
Probiotic amelioration of azotemia in 5/6th nephrectomized Sprague-Dawley rats
Natarajan Ranganathan et al.
THESCIENTIFICWORLDJOURNAL (2005)
An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system
SK Mazmanian et al.
CELL (2005)
The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice
O Ivanovski et al.
KIDNEY INTERNATIONAL (2005)
Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: Results of the HOPE study
JFE Mann et al.
KIDNEY INTERNATIONAL (2004)
Oxidative stress is enhanced in correlation with renal dysfunction: Examination with the redox state of albumin
H Terawaki et al.
KIDNEY INTERNATIONAL (2004)
Evidence for impaired assimilation of protein in chronic renal failure
B Bammens et al.
KIDNEY INTERNATIONAL (2003)
Review on uremic toxins:: Classification, concentration, and interindividual variability
R Vanholder et al.
KIDNEY INTERNATIONAL (2003)
Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis
F Takayama et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure - A randomized, controlled trial
M Tepel et al.
CIRCULATION (2003)
Uremic toxins overload accelerates renal damage in a rat model of chronic renal failure
M Satoh et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2003)
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
J Himmelfarb et al.
KIDNEY INTERNATIONAL (2002)
Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial
M Boaz et al.
LANCET (2000)
分享论文
